文献速递心外重症与机械循环支持

儿童心室辅助装置患者卒中:Pedimacs登记分析

Stroke in pediatric ventricular assist device patients-a pedimacs registry analysis.
PubMed 文献 · J Heart Lung Transplant · 2021-03-12

基于Pedimacs登记2012年9月至2019年6月数据,分析662例儿童心室辅助装置(VAD)患者,66例(10.7%)发生脑血管意外(CVA)。近期时代(2017年6月后)和体内连续流植入具保护作用,CVA后死亡率更高。

要点

  • 儿童VAD患者CVA发生率为10.7%(71/662)。
  • 近期时代和体内连续流植入与CVA风险降低相关。
  • CVA诊断后死亡率高于无CVA患者。

核心结论

  • CVA仍是儿童VAD支持中的问题,但总体比例已低于11%。
  • 近期时代数据令人鼓舞,但CVA仍与死亡率显著相关。
  • 未来应关注植入前和早期支持阶段。

研究设计与样本

  • Pedimacs登记分析,纳入2012年9月至2019年6月662例儿童VAD患者。
  • 采用多相参数风险模型确定危险因素。
  • 比较CVA患者与无CVA患者的结局。

主要发现

  • 71例患者(10.7%)发生87次CVA事件。
  • CVA患者比例在体外搏动组最高(16.9%),其次为体外连续流组(10.4%)。
  • CVA发生率在体外搏动组低于体外连续流组(6.4 vs 11.1事件/100患者月)。
  • 腹水、较高患者状态分组和小容量中心植入与CVA发生相关。
  • CVA诊断后死亡率高于无CVA诊断患者。

临床怎么用

  • 儿童VAD患者需警惕CVA风险,尤其存在腹水、较高状态分组或小容量中心植入时。
  • 近期时代和体内连续流植入可能降低CVA风险。
  • CVA发生后应关注死亡率升高风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebralvascular accidents (CVA) are common complications of pediatric ventricular assist devices (VADs). We employed the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) to investigate rates, risk factors, and outcomes of CVA in pediatric patients supported on VAD. METHODS: Analysis of Pedimacs (September 2012-June 2019) data to determine rates of all neurologic events and specifically CVA. Risk factors were determined by a multiphase parametric hazard model. Outcomes of patients with CVA were compared with patients without CVA. RESULTS: We included 662 patients in our analysis. In total, 87 CVA events occurred in 71 patients (10.7%). The proportion of patients with CVA was highest in the paracorporeal pulsatile group (16.9%) followed by the paracorporeal continuous group (10.4%). However, the rate of CVA was lower in the paracorporeal pulsatile group compared to the paracorporeal continuous group (6.4 vs 11.1 events/100 patient months), which reflects differences in support duration. Ascites, higher patient profile groups, and implants within small volume centers were associated with the occurrence of CVA. Our analysis found that the recent era (i.e., June 2017), and intracorporeal continuous implants were protective. Mortality was higher in patients following a CVA diagnosis compared to those without a CVA diagnosis. CONCLUSIONS: CVA continues to be a problem in pediatric VAD support, though the overall percent is now <11%. Data from the most recent era are encouraging, but CVA is still significantly associated with mortality. Future efforts should focus on pre-implant and early support periods.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Niebler RA, Amdani S, Blume B, et al. Stroke in pediatric ventricular assist device patients-a pedimacs registry analysis. J Heart Lung Transplant. 2021. PMID: 33824064. doi:10.1016/j.healun.2021.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。